ICCS 2026 adds an analytical-performance poster to CellMek SPS dry-tube automation
Summary
Beckman Coulter lists an ICCS 2026 poster on analytical performance of an automated dry-tube workflow using CellMek SPS, adding conference evidence to its existing dry-reagent automation platform.
Source Date
Source checked
October 6, 2026
Event Type
ICCS scientific poster / automated dry-reagent workflow evidence signal
Event Date
Geography
ICCS 2026, Miami, USA / product availability jurisdiction-specific
Commercial Regulatory Status
Existing CellMek SPS platform with dry-reagent module; the poster is included in the ICCS 2026 program. The listing does not verify a completed presentation day or analytical results. LUCID custom panels are RUO; product/use status is jurisdiction-specific.
Related CFCM Topics
ICCS 2026; Automation; Dry Reagents; Sample Preparation; QC; Validation & Verification; Technology Radar
Category
Technology
Primary source
Read the source →Facts supported by cited sources
Beckman Coulter lists an ICCS 2026 poster titled Analytical Performance of an Automated Dry Tube Workflow Using the CellMek SPS System. Its current Dry Reagent Module page states that CellMek SPS can automate dry-tube preparation, supports up to two 25-tube carousels (50 tubes total), and also supports DURACartridges up to 144 tests across two carousels.
CFCM explainer
Barcoded dry reagent → automated reconstitution/mixing → sample preparation → worklist-linked acquisition.
Source/credit: CFCM workflow schematic based on Beckman Coulter ICCS and Dry Reagent Module pages. Alt text: barcoded dry reagent moving through automated reconstitution and sample preparation into linked flow acquisition.
Claims Requiring Caution
The public ICCS page does not expose the poster's analytical-performance numbers, acceptance criteria or study design. Platform workflow specifications should not be converted into claims of assay equivalence or clinical validation without the full poster/data.
Why It Matters
Dry reagents remove one source of operator-dependent cocktail preparation, while automation can standardize reconstitution and sample handling. The evidence question is whether that translates into reproducible marker intensity, population recovery, carryover performance and between-run/between-site equivalence.
An announcement is not proof of availability or authorisation. Interpret status within the stated jurisdiction and evidence boundary.
Editor and independence disclosure →